Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Yasushi, Asano"'
Autor:
Marina Kohara, Takahiro Masuda, Kazuhiro Shiizaki, Tetsu Akimoto, Yuko Watanabe, Sumiko Honma, Chuji Sekiguchi, Yasuharu Miyazawa, Eiji Kusano, Yoshinobu Kanda, Yasushi Asano, Makoto Kuro-O, Daisuke Nagata
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178971 (2017)
Fibroblast growth factor 21 (FGF21) is an endocrine factor that regulates glucose and lipid metabolism. Circulating FGF21 predicts cardiovascular events and mortality in type 2 diabetes mellitus, including early-stage chronic kidney disease, but its
Externí odkaz:
https://doaj.org/article/f9e33daf9bdd49f091fea62fdf0c4e22
Publikováno v:
Journal of Central Nervous System Disease, Vol 2014, Iss 6, Pp 15-20 (2014)
Externí odkaz:
https://doaj.org/article/4dc0495e2ae64076a0667328f5f191f5
Autor:
Naoko Otani-Takei, Takahiro Masuda, Tetsu Akimoto, Sumiko Honma, Yuko Watanabe, Kazuhiro Shiizaki, Takuya Miki, Eiji Kusano, Yasushi Asano, Makoto Kuro-o, Daisuke Nagata
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
Klotho is a single-pass transmembrane protein predominantly expressed in the kidney. The extracellular domain of Klotho is subject to ectodomain shedding and is released into the circulation as a soluble form. Soluble Klotho is also generated from al
Externí odkaz:
https://doaj.org/article/fefa61c883f24454bf5427e7db6300a5
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
Autor:
Kazuhiro Shiizaki, Takahiro Masuda, Eiji Kusano, Sumiko Honma, Yasuharu Miyazawa, Marina Kohara, Daisuke Nagata, Makoto Kuro-o, Yasushi Asano, Tetsu Akimoto, Yuko Watanabe, Chuji Sekiguchi, Yoshinobu Kanda
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178971 (2017)
PLoS ONE
PLoS ONE
Fibroblast growth factor 21 (FGF21) is an endocrine factor that regulates glucose and lipid metabolism. Circulating FGF21 predicts cardiovascular events and mortality in type 2 diabetes mellitus, including early-stage chronic kidney disease, but its
Autor:
Akihiko Tokue, Yoshitaka Iwazu, Eiji Kusano, Yukio Miyata, Yasushi Asano, Masanori Ochi, Shigeaki Muto
Publikováno v:
Clinical Nephrology. 79:81-84
A 50-year-old female patient who presented with intermittent gross hematuria was referred to our hospital. Three-dimensional computed tomography (3D-CT) revealed a left renal arteriovenous malformation (AVM). Because she declined to undergo additiona
Autor:
Shiho Hanawa-Yazawa, Nobuhiro Sasaki, Yoshitaka Iwazu, Sumiko Honma, Eiji Kusano, Takahiro Masuda, Yasushi Asano
Publikováno v:
Clinical Kidney Journal
Obstructive sleep apnea (OSA) is common in patients with renal disease, and an association between OSA and proteinuria has been proposed. However, the effect on proteinuria of OSA treatment with continuous positive airway pressure (CPAP) is unknown.
Autor:
Chiharu, Ito, Tetsu, Akimoto, Yoshiyuki, Morishita, Hisashi, Yamamoto, Manabu, Ogura, Tomoyuki, Yamazaki, Atsushi, Miki, Sumiko, Homma, Eiji, Kusano, Yasushi, Asano, Daisuke, Nagata
Publikováno v:
Nihon Jinzo Gakkai shi. 57(7)
Erythropoiesis-stimulating agents (ESAs) are the mainstay of treatment for renal anemia in chronic kidney disease (CKD) patients. However, the difference in hematopoietic effect between darbepoetin alfa (DA) and continuous erythropoiesis receptor act
Autor:
Takahiro Masuda, Yoshitaka Iwazu, Kazuyuki Shimada, Sumiko Honma, Nobuhiro Sasaki, Mitsunobu Murata, Yasushi Asano, Kazuomi Kario, Shigeaki Muto, Manabu Ogura, Akira Onishi, Eiji Kusano, Yasuhiro Ando
Publikováno v:
Nephrology Dialysis Transplantation. 26:2289-2295
Background Sleep-disordered breathing (SDB), characterized by repetitive apnea and hypopnea during sleep, is a risk factor for cardiovascular disease. However, the links between SDB and cardiovascular events in hemodialysis (HD) patients have not bee
Autor:
Takafumi Wakita, Tadao Akizawa, Kiyoshi Kurokawa, Shunichi Fukuhara, Yasuaki Hayashino, Yasushi Asano, Yoshihiro Onishi
Publikováno v:
Diabetes Research and Clinical Practice. 90:154-159
Aims AST-120, an oral adsorbent currently on-label only in Asian countries with phase III trials ongoing in the US, slows renal disease progression in patients with diabetes and advanced-stage chronic kidney disease (CKD). The objective of this study
Publikováno v:
Clinical and Experimental Nephrology. 13:447-451
It is very important, but not clear, how physicians differ from nephrologists in treatment of renal insufficiency.To demonstrate differences in decision-making in treatment of renal insufficiency between physicians and nephrologists.Postal questionna